{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T19:37:41Z","timestamp":1761766661941,"version":"3.37.3"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,12,19]],"date-time":"2019-12-19T00:00:00Z","timestamp":1576713600000},"content-version":"vor","delay-in-days":18,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001691","name":"The Japan Society for the Promotion of Science","doi-asserted-by":"crossref","award":["JP15K09345, JP18K07541"],"award-info":[{"award-number":["JP15K09345, JP18K07541"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Project Research Grants of Kawasaki Medical School","award":["29KI023, 30KI035"],"award-info":[{"award-number":["29KI023, 30KI035"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virol J"],"published-print":{"date-parts":[[2019,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>EOS plays an important role in maintaining the suppressive function of regulatory T cells (Tregs), and induces a regulated transformation of Tregs into T helper-like cells, which are capable of secreting proinflammatory cytokines in response to specific inflammatory signals. Meanwhile, significant reduction in Treg activity along with production of proinflammatory cytokines has been reported in patients with HTLV-1-associated myelopathy\/tropical spastic paraparesis (HAM\/TSP).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>In this study, to examine whether there is an alteration in EOS expression in peripheral blood mononuclear cells (PBMCs) derived from HTLV-1-infected individuals especially HAM\/TSP, we investigated the expression of HTLV-1 tax genotype, proviral load (PVL), and the mRNA expression of tax, HBZ and EOS in HTLV-1 infected individuals including adult T-cell leukemia\/lymphoma (ATL), HAM\/TSP, or asymptomatic carriers. The expression levels of EOS mRNA and protein in various HTLV-1-infected or uninfected human T-cell lines were also investigated.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>EOS was highly expressed at the protein level in most HTLV-1 infected T-cell lines, and was augmented after the HTLV-1 regulatory factor Tax was induced in a Tax-inducible JPX-9 cell line. Immunoprecipitation experiments demonstrated a physical interaction between EOS and the viral regulatory protein Tax, but not HBZ. Meanwhile, there was a significant decrease in EOS mRNA levels in PBMCs of HTLV-1 infected individuals irrespective of their clinical statuses. We found an inverse correlation between EOS mRNA levels and HTLV-1 PVL in ATL patients, and positive correlations between both EOS mRNA load and PVL, and EOS and HBZ mRNA load in HAM\/TSP patients, whereas this correlation was not observed in other clinical statuses.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>These findings suggest that both Tax and HBZ can alter the expression of EOS through undetermined mechanisms, and dysregulated expression of EOS in PBMCs of HTLV-1 infected individuals may contribute to the pathological progression of HTLV-1-associated diseases, such as ATL and HAM\/TSP.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12985-019-1270-1","type":"journal-article","created":{"date-parts":[[2019,12,19]],"date-time":"2019-12-19T18:03:25Z","timestamp":1576778605000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["EOS, an Ikaros family zinc finger transcription factor, interacts with the HTLV-1 oncoprotein Tax and is downregulated in peripheral blood mononuclear cells of HTLV-1-infected individuals, irrespective of clinical statuses"],"prefix":"10.1186","volume":"16","author":[{"given":"Tadasuke","family":"Naito","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Ushirogawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takuya","family":"Fukushima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuetsu","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8208-5586","authenticated-orcid":false,"given":"Mineki","family":"Saito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,12,19]]},"reference":[{"key":"1270_CR1","doi-asserted-by":"publisher","first-page":"7415","DOI":"10.1073\/pnas.77.12.7415","volume":"77","author":"BJ Poiesz","year":"1980","unstructured":"Poiesz BJ, Ruscetti FW, Gazdar AF, Bunn PA, Minna JD, Gallo RC. Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc Natl Acad Sci U S A. 1980;77:7415\u20139.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1270_CR2","doi-asserted-by":"publisher","first-page":"6476","DOI":"10.1073\/pnas.78.10.6476","volume":"78","author":"Y Hinuma","year":"1981","unstructured":"Hinuma Y, Nagata K, Hanaoka M, Nakai M, Matsumoto T, Kinoshita KI, Shirakawa S, Miyoshi I. Adult T-cell leukemia: antigen in an ATL cell line and detection of antibodies to the antigen in human sera. Proc Natl Acad Sci U S A. 1981;78:6476\u201380.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1270_CR3","doi-asserted-by":"publisher","first-page":"2534","DOI":"10.1073\/pnas.81.8.2534","volume":"81","author":"M Yoshida","year":"1984","unstructured":"Yoshida M, Seiki M, Yamaguchi K, Takatsuki K. Monoclonal integration of human T-cell leukemia provirus in all primary tumors of adult T-cell leukemia suggests causative role of human T-cell leukemia virus in the disease. Proc Natl Acad Sci U S A. 1984;81:2534\u20137.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1270_CR4","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/S0140-6736(85)92734-5","volume":"2","author":"A Gessain","year":"1985","unstructured":"Gessain A, Barin F, Vernant JC, Gout O, Maurs L, Calender A, de The G. Antibodies to human T-lymphotropic virus type-I in patients with tropical spastic paraparesis. Lancet. 1985;2:407\u201310.","journal-title":"Lancet"},{"key":"1270_CR5","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1016\/S0140-6736(86)91298-5","volume":"1","author":"M Osame","year":"1986","unstructured":"Osame M, Usuku K, Izumo S, Ijichi N, Amitani H, Igata A, Matsumoto M, Tara M. HTLV-I associated myelopathy, a new clinical entity. Lancet. 1986;1:1031\u20132.","journal-title":"Lancet"},{"key":"1270_CR6","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1007\/s004010050903","volume":"96","author":"E Matsuoka","year":"1998","unstructured":"Matsuoka E, Takenouchi N, Hashimoto K, Kashio N, Moritoyo T, Higuchi I, Isashiki Y, Sato E, Osame M, Izumo S. Perivascular T cells are infected with HTLV-I in the spinal cord lesions with HTLV-I-associated myelopathy\/tropical spastic paraparesis: double staining of immunohistochemistry and polymerase chain reaction in situ hybridization. Acta Neuropathol. 1998;96:340\u20136.","journal-title":"Acta Neuropathol"},{"issue":"Suppl","key":"1270_CR7","doi-asserted-by":"publisher","first-page":"S65","DOI":"10.1046\/j.1440-1789.2000.00320.x","volume":"20","author":"S Izumo","year":"2000","unstructured":"Izumo S, Umehara F, Osame M. HTLV-I-associated myelopathy. Neuropathology. 2000;20(Suppl):S65\u20138.","journal-title":"Neuropathology"},{"key":"1270_CR8","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1080\/13550280260422668","volume":"8","author":"M Osame","year":"2002","unstructured":"Osame M. Pathological mechanisms of human T-cell lymphotropic virus type I-associated myelopathy (HAM\/TSP). J Neurovirol. 2002;8:359\u201364.","journal-title":"J Neurovirol"},{"key":"1270_CR9","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1182\/blood.V98.3.721","volume":"98","author":"E Hanon","year":"2001","unstructured":"Hanon E, Goon P, Taylor GP, Hasegawa H, Tanaka Y, Weber JN, Bangham CR. High production of interferon gamma but not interleukin-2 by human T-lymphotropic virus type I-infected peripheral blood mononuclear cells. Blood. 2001;98:721\u20136.","journal-title":"Blood"},{"key":"1270_CR10","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/S0165-5728(99)00175-7","volume":"102","author":"R Kubota","year":"2000","unstructured":"Kubota R, Kawanishi T, Matsubara H, Manns A, Jacobson S. HTLV-I specific IFN-gamma+ CD8+ lymphocytes correlate with the proviral load in peripheral blood of infected individuals. J Neuroimmunol. 2000;102:208\u201315.","journal-title":"J Neuroimmunol"},{"key":"1270_CR11","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1002\/ana.10065","volume":"50","author":"M Nagai","year":"2001","unstructured":"Nagai M, Yamano Y, Brennan MB, Mora CA, Jacobson S. Increased HTLV-I proviral load and preferential expansion of HTLV-I tax-specific CD8+ T cells in cerebrospinal fluid from patients with HAM\/TSP. Ann Neurol. 2001;50:807\u201312.","journal-title":"Ann Neurol"},{"key":"1270_CR12","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1007\/s11481-010-9216-9","volume":"5","author":"E Matsuura","year":"2010","unstructured":"Matsuura E, Yamano Y, Jacobson S. Neuroimmunity of HTLV-I infection. J NeuroImmune Pharmacol. 2010;5:310\u201325.","journal-title":"J NeuroImmune Pharmacol"},{"key":"1270_CR13","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/nrc2111","volume":"7","author":"M Matsuoka","year":"2007","unstructured":"Matsuoka M, Jeang KT. Human T-cell leukaemia virus type 1 (HTLV-1) infectivity and cellular transformation. Nat Rev Cancer. 2007;7:270\u201380.","journal-title":"Nat Rev Cancer"},{"key":"1270_CR14","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1172\/JCI23913","volume":"115","author":"Y Yamano","year":"2005","unstructured":"Yamano Y, Takenouchi N, Li HC, Tomaru U, Yao K, Grant CW, Maric DA, Jacobson S. Virus-induced dysfunction of CD4+CD25+ T cells in patients with HTLV-I-associated neuroimmunological disease. J Clin Invest. 2005;115:1361\u20138.","journal-title":"J Clin Invest"},{"key":"1270_CR15","doi-asserted-by":"publisher","first-page":"3431","DOI":"10.1172\/JCI75250","volume":"124","author":"N Araya","year":"2014","unstructured":"Araya N, Sato T, Ando H, Tomaru U, Yoshida M, Coler-Reilly A, Yagishita N, Yamauchi J, Hasegawa A, Kannagi M, et al. HTLV-1 induces a Th1-like state in CD4+CCR4+ T cells. J Clin Invest. 2014;124:3431\u201342.","journal-title":"J Clin Invest"},{"key":"1270_CR16","doi-asserted-by":"publisher","first-page":"e1001274","DOI":"10.1371\/journal.ppat.1001274","volume":"7","author":"Y Satou","year":"2011","unstructured":"Satou Y, Yasunaga J, Zhao T, Yoshida M, Miyazato P, Takai K, Shimizu K, Ohshima K, Green PL, Ohkura N, et al. HTLV-1 bZIP factor induces T-cell lymphoma and systemic inflammation in vivo. PLoS Pathog. 2011;7:e1001274.","journal-title":"PLoS Pathog"},{"key":"1270_CR17","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1111\/j.0105-2896.2006.00427.x","volume":"212","author":"S Sakaguchi","year":"2006","unstructured":"Sakaguchi S, Ono M, Setoguchi R, Yagi H, Hori S, Fehervari Z, Shimizu J, Takahashi T, Nomura T. Foxp3+ CD25+ CD4+ natural regulatory T cells in dominant self-tolerance and autoimmune disease. Immunol Rev. 2006;212:8\u201327.","journal-title":"Immunol Rev"},{"key":"1270_CR18","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1080\/13550280802178538","volume":"14","author":"D Hayashi","year":"2008","unstructured":"Hayashi D, Kubota R, Takenouchi N, Nakamura T, Umehara F, Arimura K, Izumo S, Osame M. Accumulation of human T-lymphotropic virus type I (HTLV-I)-infected cells in the cerebrospinal fluid during the exacerbation of HTLV-I-associated myelopathy. J Neurovirol. 2008;14:459\u201363.","journal-title":"J Neurovirol"},{"key":"1270_CR19","doi-asserted-by":"publisher","first-page":"5047","DOI":"10.1182\/blood-2007-10-118539","volume":"111","author":"F Toulza","year":"2008","unstructured":"Toulza F, Heaps A, Tanaka Y, Taylor GP, Bangham CR. High frequency of CD4+FoxP3+ cells in HTLV-1 infection: inverse correlation with HTLV-1-specific CTL response. Blood. 2008;111:5047\u201353.","journal-title":"Blood"},{"key":"1270_CR20","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.1126\/science.1176077","volume":"325","author":"F Pan","year":"2009","unstructured":"Pan F, Yu H, Dang EV, Barbi J, Pan X, Grosso JF, Jinasena D, Sharma SM, EM MC, Getnet D, et al. Eos mediates Foxp3-dependent gene silencing in CD4+ regulatory T cells. Science. 2009;325:1142\u20136.","journal-title":"Science"},{"key":"1270_CR21","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.coi.2017.11.005","volume":"51","author":"B Heizmann","year":"2018","unstructured":"Heizmann B, Kastner P, Chan S. The Ikaros family in lymphocyte development. Curr Opin Immunol. 2018;51:14\u201323.","journal-title":"Curr Opin Immunol"},{"key":"1270_CR22","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.leukres.2017.08.006","volume":"61","author":"Shugo Sakihama","year":"2017","unstructured":"Sakihama S, Saito M, Kuba-Miyara M, Tomoyose T, Taira N, Miyagi T, Hayashi M, Kinjo S, Nakachi S, Tedokon I, et al: Human T-cell leukemia virus type I tax genotype analysis in Okinawa, the southernmost and remotest islands of Japan: different distributions compared with mainland Japan and the potential value for the prognosis of aggressive adult T-cell leukemia\/lymphoma. Leuk Res 2017, 61:18\u201324.","journal-title":"Leukemia Research"},{"key":"1270_CR23","volume-title":"Review of WHO Kagoshima meeting and diagnostic guidelines for HAM\/TSP","author":"M Osame","year":"1990","unstructured":"Osame M. Review of WHO Kagoshima meeting and diagnostic guidelines for HAM\/TSP. New York: Raven Press; 1990."},{"key":"1270_CR24","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1111\/j.1365-2141.1991.tb08051.x","volume":"79","author":"M Shimoyama","year":"1991","unstructured":"Shimoyama M. Diagnostic criteria and classification of clinical subtypes of adult T-cell leukaemia-lymphoma. A report from the lymphoma study group (1984-87). Br J Haematol. 1991;79:428\u201337.","journal-title":"Br J Haematol"},{"key":"1270_CR25","first-page":"155","volume":"71","author":"I Miyoshi","year":"1980","unstructured":"Miyoshi I, Kubonishi I, Sumida M, Hiraki S, Tsubota T, Kimura I, Miyamoto K, Sato J. A novel T-cell line derived from adult T-cell leukemia. Gan. 1980;71:155\u20136.","journal-title":"Gan"},{"key":"1270_CR26","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1038\/294770a0","volume":"294","author":"I Miyoshi","year":"1981","unstructured":"Miyoshi I, Kubonishi I, Yoshimoto S, Akagi T, Ohtsuki Y, Shiraishi Y, Nagata K, Hinuma Y. Type C virus particles in a cord T-cell line derived by co-cultivating normal human cord leukocytes and human leukaemic T cells. Nature. 1981;294:770\u20131.","journal-title":"Nature"},{"key":"1270_CR27","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/0042-6822(85)90010-8","volume":"146","author":"S Harada","year":"1985","unstructured":"Harada S, Koyanagi Y, Yamamoto N. Infection of human T-lymphotropic virus type-I (HTLV-I)-bearing MT-4 cells with HTLV-III (AIDS virus): chronological studies of early events. Virology. 1985;146:272\u201381.","journal-title":"Virology"},{"key":"1270_CR28","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1182\/blood.V55.3.409.409","volume":"55","author":"AF Gazdar","year":"1980","unstructured":"Gazdar AF, Carney DN, Bunn PA, Russell EK, Jaffe ES, Schechter GP, Guccion JG. Mitogen requirements for the in vitro propagation of cutaneous T-cell lymphomas. Blood. 1980;55:409\u201317.","journal-title":"Blood"},{"key":"1270_CR29","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/0140-6736(91)90737-A","volume":"337","author":"T Hattori","year":"1991","unstructured":"Hattori T, Asou N, Suzushima H, Takatsuki K, Tanaka K, Naito K, Natori H, Oizumi K. Leukaemia of novel gastrointestinal T-lymphocyte population infected with HTLV-I. Lancet. 1991;337:76\u20137.","journal-title":"Lancet"},{"key":"1270_CR30","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1182\/blood.V70.5.1407.1407","volume":"70","author":"M Maeda","year":"1987","unstructured":"Maeda M, Arima N, Daitoku Y, Kashihara M, Okamoto H, Uchiyama T, Shirono K, Matsuoka M, Hattori T, Takatsuki K, et al. Evidence for the interleukin-2 dependent expansion of leukemic cells in adult T cell leukemia. Blood. 1987;70:1407\u201311.","journal-title":"Blood"},{"key":"1270_CR31","doi-asserted-by":"publisher","first-page":"2169","DOI":"10.1084\/jem.162.6.2169","volume":"162","author":"M Maeda","year":"1985","unstructured":"Maeda M, Shimizu A, Ikuta K, Okamoto H, Kashihara M, Uchiyama T, Honjo T, Yodoi J. Origin of human T-lymphotrophic virus I-positive T cell lines in adult T cell leukemia. Analysis of T cell receptor gene rearrangement. J Exp Med. 1985;162:2169\u201374.","journal-title":"J Exp Med"},{"key":"1270_CR32","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1002\/ijc.2910340213","volume":"34","author":"K Sugamura","year":"1984","unstructured":"Sugamura K, Fujii M, Kannagi M, Sakitani M, Takeuchi M, Hinuma Y. Cell surface phenotypes and expression of viral antigens of various human cell lines carrying human T-cell leukemia virus. Int J Cancer. 1984;34:221\u20138.","journal-title":"Int J Cancer"},{"key":"1270_CR33","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1182\/blood.V64.2.482.482","volume":"64","author":"HP Koeffler","year":"1984","unstructured":"Koeffler HP, Chen IS, Golde DW. Characterization of a novel HTLV-infected cell line. Blood. 1984;64:482\u201390.","journal-title":"Blood"},{"key":"1270_CR34","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1089\/aid.2013.0214","volume":"30","author":"Y Tanaka","year":"2014","unstructured":"Tanaka Y, Takahashi Y, Tanaka R, Kodama A, Fujii H, Hasegawa A, Kannagi M, Ansari AA, Saito M. Elimination of human T cell leukemia virus type-1-infected cells by neutralizing and antibody-dependent cellular cytotoxicity-inducing antibodies against human t cell leukemia virus type-1 envelope gp46. AIDS Res Hum Retroviruses. 2014;30:542\u201352.","journal-title":"AIDS Res Hum Retroviruses"},{"key":"1270_CR35","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1007\/BF00321034","volume":"54","author":"HG Drexler","year":"1987","unstructured":"Drexler HG, Gaedicke G, Minowada J. T-leukemia cell lines CCRF-CEM, HPB-ALL, JM and MOLT-4: changes in isoenzyme profiles during induction of differentiation. Blut. 1987;54:79\u201387.","journal-title":"Blut"},{"key":"1270_CR36","doi-asserted-by":"publisher","first-page":"1709","DOI":"10.1084\/jem.152.6.1709","volume":"152","author":"S Gillis","year":"1980","unstructured":"Gillis S, Watson J. Biochemical and biological characterization of lymphocyte regulatory molecules. V. Identification of an interleukin 2-producing human leukemia T cell line. J Exp Med. 1980;152:1709\u201319.","journal-title":"J Exp Med"},{"key":"1270_CR37","doi-asserted-by":"crossref","first-page":"3220","DOI":"10.1128\/JVI.63.8.3220-3226.1989","volume":"63","author":"K Nagata","year":"1989","unstructured":"Nagata K, Ohtani K, Nakamura M, Sugamura K. Activation of endogenous c-fos proto-oncogene expression by human T-cell leukemia virus type I-encoded p40tax protein in the human T-cell line, Jurkat. J Virol. 1989;63:3220\u20136.","journal-title":"J Virol"},{"key":"1270_CR38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1620\/tjem.157.1","volume":"157","author":"B Lee","year":"1989","unstructured":"Lee B, Tanaka Y, Tozawa H. Monoclonal antibody defining tax protein of human T-cell leukemia virus type-I. Tohoku J Exp Med. 1989;157:1\u201311.","journal-title":"Tohoku J Exp Med"},{"key":"1270_CR39","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1186\/s12977-018-0454-x","volume":"15","author":"T Naito","year":"2018","unstructured":"Naito T, Yasunaga JI, Mitobe Y, Shirai K, Sejima H, Ushirogawa H, Tanaka Y, Nakamura T, Hanada K, Fujii M, et al. Distinct gene expression signatures induced by viral transactivators of different HTLV-1 subgroups that confer a different risk of HAM\/TSP. Retrovirology. 2018;15:72.","journal-title":"Retrovirology"},{"key":"1270_CR40","doi-asserted-by":"publisher","first-page":"e1005372","DOI":"10.1371\/journal.ppat.1005372","volume":"12","author":"K Yasuma","year":"2016","unstructured":"Yasuma K, Yasunaga J, Takemoto K, Sugata K, Mitobe Y, Takenouchi N, Nakagawa M, Suzuki Y, Matsuoka M. HTLV-1 bZIP factor impairs anti-viral immunity by inducing co-inhibitory molecule, T cell immunoglobulin and ITIM domain (TIGIT). PLoS Pathog. 2016;12:e1005372.","journal-title":"PLoS Pathog"},{"key":"1270_CR41","doi-asserted-by":"publisher","first-page":"586","DOI":"10.3109\/13550289809114225","volume":"4","author":"M Nagai","year":"1998","unstructured":"Nagai M, Usuku K, Matsumoto W, Kodama D, Takenouchi N, Moritoyo T, Hashiguchi S, Ichinose M, Bangham CR, Izumo S, Osame M. Analysis of HTLV-I proviral load in 202 HAM\/TSP patients and 243 asymptomatic HTLV-I carriers: high proviral load strongly predisposes to HAM\/TSP. J Neurovirol. 1998;4:586\u201393.","journal-title":"J Neurovirol"},{"key":"1270_CR42","doi-asserted-by":"publisher","first-page":"3488","DOI":"10.1182\/blood-2012-07-445593","volume":"120","author":"LB Cook","year":"2012","unstructured":"Cook LB, Rowan AG, Melamed A, Taylor GP, Bangham CR. HTLV-1-infected T cells contain a single integrated provirus in natural infection. Blood. 2012;120:3488\u201390.","journal-title":"Blood"},{"key":"1270_CR43","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/1742-4690-6-19","volume":"6","author":"M Saito","year":"2009","unstructured":"Saito M, Matsuzaki T, Satou Y, Yasunaga J, Saito K, Arimura K, Matsuoka M, Ohara Y. In vivo expression of the HBZ gene of HTLV-1 correlates with proviral load, inflammatory markers and disease severity in HTLV-1 associated myelopathy\/tropical spastic paraparesis (HAM\/TSP). Retrovirology. 2009;6:19.","journal-title":"Retrovirology"},{"key":"1270_CR44","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.3389\/fimmu.2019.01299","volume":"10","author":"MD Powell","year":"2019","unstructured":"Powell MD, Read KA, Sreekumar BK, Oestreich KJ. Ikaros zinc finger transcription factors: regulators of cytokine signaling pathways and CD4(+) T helper cell differentiation. Front Immunol. 2019;10:1299.","journal-title":"Front Immunol"},{"key":"1270_CR45","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1111\/bjh.13342","volume":"169","author":"L Olsson","year":"2015","unstructured":"Olsson L, Johansson B. Ikaros and leukaemia. Br J Haematol. 2015;169:479\u201391.","journal-title":"Br J Haematol"},{"key":"1270_CR46","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1016\/j.coviro.2013.08.010","volume":"3","author":"M Matsuoka","year":"2013","unstructured":"Matsuoka M, Yasunaga J. Human T-cell leukemia virus type 1: replication, proliferation and propagation by tax and HTLV-1 bZIP factor. Curr Opin Virol. 2013;3:684\u201391.","journal-title":"Curr Opin Virol"},{"key":"1270_CR47","doi-asserted-by":"publisher","first-page":"5952","DOI":"10.1038\/sj.onc.1208969","volume":"24","author":"SC Sun","year":"2005","unstructured":"Sun SC, Yamaoka S. Activation of NF-kappaB by HTLV-I and implications for cell transformation. Oncogene. 2005;24:5952\u201364.","journal-title":"Oncogene"},{"key":"1270_CR48","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1186\/1742-4690-5-76","volume":"5","author":"M Boxus","year":"2008","unstructured":"Boxus M, Twizere JC, Legros S, Dewulf JF, Kettmann R, Willems L. The HTLV-1 tax interactome. Retrovirology. 2008;5:76.","journal-title":"Retrovirology"},{"key":"1270_CR49","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1182\/blood-2016-09-692574","volume":"129","author":"T Watanabe","year":"2017","unstructured":"Watanabe T. Adult T-cell leukemia: molecular basis for clonal expansion and transformation of HTLV-1-infected T cells. Blood. 2017;129:1071\u201381.","journal-title":"Blood"},{"key":"1270_CR50","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1007\/s11481-014-9547-z","volume":"9","author":"MR Anderson","year":"2014","unstructured":"Anderson MR, Enose-Akahata Y, Massoud R, Ngouth N, Tanaka Y, Oh U, Jacobson S. Epigenetic modification of the FoxP3 TSDR in HAM\/TSP decreases the functional suppression of Tregs. J NeuroImmune Pharmacol. 2014;9:522\u201332.","journal-title":"J NeuroImmune Pharmacol"},{"key":"1270_CR51","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/1742-4690-9-46","volume":"9","author":"Y Satou","year":"2012","unstructured":"Satou Y, Utsunomiya A, Tanabe J, Nakagawa M, Nosaka K, Matsuoka M. HTLV-1 modulates the frequency and phenotype of FoxP3+CD4+ T cells in virus-infected individuals. Retrovirology. 2012;9:46.","journal-title":"Retrovirology"},{"key":"1270_CR52","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1073\/pnas.0507631103","volume":"103","author":"Y Satou","year":"2006","unstructured":"Satou Y, Yasunaga J, Yoshida M, Matsuoka M. HTLV-I basic leucine zipper factor gene mRNA supports proliferation of adult T cell leukemia cells. Proc Natl Acad Sci U S A. 2006;103:720\u20135.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1270_CR53","doi-asserted-by":"publisher","first-page":"50","DOI":"10.3109\/13550289509111010","volume":"1","author":"M Nakagawa","year":"1995","unstructured":"Nakagawa M, Izumo S, Ijichi S, Kubota H, Arimura K, Kawabata M, Osame M. HTLV-I-associated myelopathy: analysis of 213 patients based on clinical features and laboratory findings. J Neurovirol. 1995;1:50\u201361.","journal-title":"J Neurovirol"},{"key":"1270_CR54","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1093\/intimm\/dxu048","volume":"26","author":"P Miyazato","year":"2014","unstructured":"Miyazato P, Matsuoka M. Human T-cell leukemia virus type 1 and Foxp3 expression: viral strategy in vivo. Int Immunol. 2014;26:419\u201325.","journal-title":"Int Immunol"},{"key":"1270_CR55","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1007\/s13365-013-0192-8","volume":"20","author":"M Saito","year":"2014","unstructured":"Saito M. Neuroimmunological aspects of human T cell leukemia virus type 1-associated myelopathy\/tropical spastic paraparesis. J Neurovirol. 2014;20:164\u201374.","journal-title":"J Neurovirol"},{"key":"1270_CR56","doi-asserted-by":"publisher","first-page":"553","DOI":"10.4049\/jimmunol.1500627","volume":"195","author":"SA Rieder","year":"2015","unstructured":"Rieder SA, Metidji A, Glass DD, Thornton AM, Ikeda T, Morgan BA, Shevach EM. Eos is redundant for regulatory T cell function but plays an important role in IL-2 and Th17 production by CD4+ conventional T cells. J Immunol. 2015;195:553\u201363.","journal-title":"J Immunol"},{"key":"1270_CR57","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1016\/j.immuni.2012.03.020","volume":"36","author":"ML Bettini","year":"2012","unstructured":"Bettini ML, Pan F, Bettini M, Finkelstein D, Rehg JE, Floess S, Bell BD, Ziegler SF, Huehn J, Pardoll DM, Vignali DA. Loss of epigenetic modification driven by the Foxp3 transcription factor leads to regulatory T cell insufficiency. Immunity. 2012;36:717\u201330.","journal-title":"Immunity"},{"key":"1270_CR58","doi-asserted-by":"crossref","unstructured":"Gokhale AS, Gangaplara A, Lopez-Occasio M, Thornton AM, Shevach EM. Selective deletion of Eos (Ikzf4) in T-regulatory cells leads to loss of suppressive function and development of systemic autoimmunity. J Autoimmun. 2019;102300.","DOI":"10.1016\/j.jaut.2019.06.011"}],"container-title":["Virology Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12985-019-1270-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12985-019-1270-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12985-019-1270-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,18]],"date-time":"2020-12-18T00:36:58Z","timestamp":1608251818000},"score":1,"resource":{"primary":{"URL":"https:\/\/virologyj.biomedcentral.com\/articles\/10.1186\/s12985-019-1270-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":58,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["1270"],"URL":"https:\/\/doi.org\/10.1186\/s12985-019-1270-1","relation":{},"ISSN":["1743-422X"],"issn-type":[{"type":"electronic","value":"1743-422X"}],"subject":[],"published":{"date-parts":[[2019,12]]},"assertion":[{"value":"17 May 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 December 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 December 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was approved by the Research Ethics Committee of Kawasaki Medical School (approval numbers: 1422\u20133 and 3447). All subjects provided written informed consent.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"160"}}